Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer - Trial NCT06301464
Access comprehensive clinical trial information for NCT06301464 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul National University Bundang Hospital and is currently Recruitment Completed. The study focuses on Gastric Cancer. Target enrollment is 24000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Seoul National University Bundang Hospital
Timeline & Enrollment
N/A
Mar 01, 2003
Dec 31, 2025
Primary Outcome
The level of serum pepsinogens
Summary
The aim of this study to validate the role of pepsinogens in gastric cancer screening.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06301464
Non-Device Trial